Skip to content

Conventional implants vs mini implants used to retain full lower dentures

A pilot randomised controlled trial of Conventional Implants vs Mini Implants used to retain full lower DENTures

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN87342238
Enrollment
44
Registered
2013-07-05
Start date
2013-11-01
Completion date
Unknown
Last updated
2017-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Oral and Gastrointestinal

Interventions

1. Conventional dental implant (Astra) 2. Mini Dental Implant (3M)

Sponsors

Central Manchester University Hospitals NHS Trust (CMFT) (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patient has been edentulous (no teeth at all) for at least 12 months 2. Bone height = 10mm in the interforamina region (anterior section of the mandible), therefore suitable for implant placement without bone grafting 3. Cawood and Howell Classification V and VI (severely resorbed mandible) 4. New lower denture remains unsatisfactory 5. Able to give informed consent to participate in the study 6. Aged 18 or over Target Gender: Male & Female ; Lower Age Limit 18 years

Exclusion criteria

Exclusion criteria: 1. Radiographic confirmation that the patient has insufficient mandibular bone for either procedure 2. Significant medical history contraindicating the placement of either conventional or miniimplants (e.g. bisphosphonate treatment, radiotherapy treatment, poorly controlled diabetes, longterm steriod use) 3. Current smoker, or have smoked in last six months 4. Unable to maintain adequate level of oral hygiene 5. Requires sedation for dental treatment 6. Previous failed implant treatment 7. Allergic to or unable to tolerate any of the ingredients of ?gummy jelly? (an outcome measure)

Design outcomes

Primary

MeasureTime frame
Inform a large randomised trial of conventional vs mini implants; Timepoint(s): Throughout conduct of the pilot trial, each patient is followed-up for 6 months post surgery.

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026